What happened to Quidel Corporation (QDEL) stock?
Mar 10, 2021 · As of 3:50 p.m. EST, Quidel stock was down almost 17%. So what. Bryant and the rest of the Quidel management team expect $450 million in revenue for the first quarter of 2021 as a worst case...
Will Quidel stock grow/rise/go up?
Jun 08, 2021 · QDEL stock did surge from levels of under $90 to levels of around $250 as recently as end of January 2021. However, the stock plummeted 57% to levels of around $108 now. Why? Because Covid-19...
What is the QDEL stock price prediction for 2027-02-12?
Feb 22, 2021 · Shares of Quidel ( QDEL -2.52% ) fell on Monday, continuing declines from last week. It seems the market was selling companies like Quidel that have grown revenue because of the COVID-19 pandemic....
How often do you update the QDEL stock prediction?
Quidel (QDEL) closed at $114.15 in the latest trading session, marking a -1.17% move from the prior day. Zacks Here's How Much You'd Have If You Invested $1000 in Quidel a Decade Ago
Investors weren't expecting demand for coronavirus testing to drop this much this soon
After spending more than a decade travelling the world exploring different cultures and languages, I'm happy to now be contributing to the Motley Fool's mission to make the world smarter, happier, and richer. What's great about exploring business and the economy is the insight it gives you into how things are in the world.
What happened
Shares of Quidel Corporation ( NASDAQ:QDEL) suddenly plunged this afternoon, following comments made by CEO Doug Bryant at the Barclays Global Healthcare Conference today.
So what
Bryant and the rest of the Quidel management team expect $450 million in revenue for the first quarter of 2021 as a worst case scenario. This projection assumes there's no new spikes in coronavirus cases going forward. The outlook also assumes that the current vaccines will remain effective against the newer mutations of the virus.
Now what
There could also be something else coming into play with today's sell-off. Wall Street largely argues that the companies that did well during the pandemic will revert to normal once it's over. Therefore, any sniff of slowing growth now is enough to cause shareholders to flood the exits with these kinds of stocks.
Investors are starting to get worried now that COVID-19 is possibly declining
After spending more than a decade travelling the world exploring different cultures and languages, I'm happy to now be contributing to the Motley Fool's mission to make the world smarter, happier, and richer. What's great about exploring business and the economy is the insight it gives you into how things are in the world.
What happened
Shares of Quidel ( NASDAQ:QDEL) fell on Monday, continuing declines from last week. It seems the market was selling companies like Quidel that have grown revenue because of the COVID-19 pandemic. That might explain why the stock fell 10% today.
So what
Quidel fell last week after reporting full-year 2020 results. Counterintuitive to the drop, the company's results were quite good. Revenue in 2020 rose to $1.66 billion, up 211% from revenue in 2019. Its rapid tests for COVID-19 obviously were in high demand for much of the year, leading to the outsize growth.
Now what
There's more to Quidel's business than COVID-19 testing. Furthermore, there is some reason to believe testing could continue well into the future. For example, some researchers are beginning to say that COVID-19 could become endemic -- in other words, it will continue to circulate and not be eradicated.
What is a Sofia Q?
(QDEL) received an amended emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Sofia Q device. Sofia Q is a Fluorescent Immunoassay Analyzer (FIA) from the company’s Sofia product portfolio that provides the same accuracy in SARS Antigen testing as Sofia and Sofia 2 and delivers automated results in 15 minutes. Quidel President and CEO Douglas Bryant said, “Sofia Q is our latest powerful diagnostic instrument desig
Is Lyra recalled?
Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus. The FDA gave the molecular COVID-19 test emergency use authorization in March 2020.
Quidel Media Sentiment
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Media Coverage
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
Quidel (NASDAQ QDEL) News Headlines Today
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
When will harvest ETFs be paid out?
Harvest Portfolios Group Inc. ("Harvest") announces the following distributions for Harvest ETFs for the month ending June 30, 2021. The distribution will be paid on or about July 9, 2021 to unitholders of record on June 30, 2021 with an ex-dividend date of June 29, 2021.
Is Lyra recalled?
Quidel Corporation (NASDAQ: QDEL) is recalling its Lyra COVID-19 Assay test due to a high risk of false-negative results in patients with high amounts of the virus. The FDA gave the molecular COVID-19 test emergency use authorization in March 2020. It uses a swab sample from the nasal area to detect RNA specific to the SARS-CoV-2 virus. “False-negative results may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2 that may cause patient harm, serious illness, and death,” the FDA
QDEL Target Price
QDEL price target in 14 days: 170.210 USD* upside and 143.977 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Quidel Corp. ( QDEL ) Stock Market info
Recommendations: Buy or sell Quidel stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Quidel share forecasts, stock quote and buy / sell signals below. According to present data Quidel's QDEL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).
Quidel Corp. ( QDEL ) Stock Price Prediction, Stock Forecast for next months and years
Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026.
Signals & Forecast
Mostly positive signals in the chart today. The Quidel Corporation stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.
Support, Risk & Stop-loss
On the downside, the stock finds support just below today's level from accumulated volume at $132.12 and $125.01. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Quidel Corporation finds support just below today's level at $132.12.
Is Quidel Corporation stock A Buy?
Quidel Corporation holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
